GERN Q3 2018 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$165,000+1.2% YoY

Gross Profit

-$2M-1083.6% margin

Operating Income

-$7M-4124.2% margin

Net Income

-$6M-3392.1% margin

EPS (Diluted)

$-0.03

QoQ Revenue Growth

-20.7%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$188M

Total Liabilities

$4M

Stockholders' Equity

$183M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$165,000	$163,000	+1.2%
Gross Profit	-$2M	-$2M	+5.0%
Operating Income	-$7M	-$7M	+6.1%
Net Income	-$6M	-$7M	+18.9%